Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole versus esomeprazole in infants with reflux disease
IRCT20191027045256N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of omeprazole and esomeprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Kashan University of Medical Sciences. Primary endpoint: Recovery. Started Oct 2019; status: completed.
02
Drugs
omeprazoleesomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on IRCT20191027045256N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191027045256N1.